A socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and sporting, public, and cultural events.

The Roscongress Foundation – a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and sporting, public, and cultural events.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 2,500 people working in Russia and abroad. In addition, it works in close cooperation with 122 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 69 countries worldwide.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Natalia Kolerova

Natalia Kolerova

General Manager, Oncology Department, Russia, Ukraine and CIS, Novartis AG
Biography
Natalia Kolerova became the Oncology General Manager at Novartis in April 2014. In this position she supervised the development of the oncological segment in Russia, Ukraine and the CIS. Since 2017, she also holds the position of General Director at Novartis Pharma LLC in Russia.

Natalia joined Novartis in 2008 as the head of a new business unit of specialized medicine. In this position, she managed to efficiently organize the operations of the unit and successfully bring six new products to the Russian market, including Galvus® and Gilenya®. Later, Natalya headed the unit of introducing pharmaceutical products into the market, where she supervised the accessibility of pharmaceuticals from the company’s oncology portfolio at the federal and regional levels.

Natalia graduated from the Sechenov Moscow Medical Academy with a degree in Pharmacology, as well as the Lomonosov Moscow State University with a degree in Sociology. She holds an MBA degree.

Before joining Novartis, Natalia held senior positions at the Russian representative offices of the international pharmaceutical companies Abbott Lab SA and Sanofi-Aventis.